Bausch Health Companies Inc. (BHC): Price and Financial Metrics


Bausch Health Companies Inc. (BHC): $7.87

0.16 (+2.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BHC POWR Grades

  • BHC scores best on the Growth dimension, with a Growth rank ahead of 98.73% of US stocks.
  • BHC's strongest trending metric is Stability; it's been moving up over the last 177 days.
  • BHC ranks lowest in Momentum; there it ranks in the 7th percentile.

BHC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for BHC is -11.74 -- better than only 1.63% of US stocks.
  • BHC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 0.35% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BHC comes in at 42.48% -- higher than that of 95.44% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to BAUSCH HEALTH COMPANIES INC, a group of peers worth examining would be LVO, RGS, CCLP, AZYO, and LCI.
  • Visit BHC's SEC page to see the company's official filings. To visit the company's web site, go to www.bauschhealth.com.

BHC Valuation Summary

  • In comparison to the median Healthcare stock, BHC's price/sales ratio is 84.21% lower, now standing at 0.3.
  • Over the past 243 months, BHC's price/sales ratio has gone down 10.8.

Below are key valuation metrics over time for BHC.

Stock Date P/S P/B P/E EV/EBIT
BHC 2023-03-24 0.3 -3.8 -11.6 17.2
BHC 2023-03-23 0.3 -3.8 -11.7 17.3
BHC 2023-03-22 0.3 -4.0 -12.2 17.3
BHC 2023-03-21 0.4 -4.1 -12.7 17.4
BHC 2023-03-20 0.3 -4.0 -12.2 17.3
BHC 2023-03-17 0.3 -4.0 -12.2 17.3

BHC Growth Metrics

    Its year over year net cashflow from operations growth rate is now at -28.85%.
  • Its year over year price growth rate is now at -66.36%.
  • The 3 year revenue growth rate now stands at -0.9%.
BHC's revenue has moved down $474,000,000 over the prior 33 months.

The table below shows BHC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8,127 -1,179 254
2022-06-30 8,192 648 43
2022-03-31 8,325 920 -407
2021-12-31 8,434 1,426 -948
2021-09-30 8,451 1,796 -1,170
2021-06-30 8,478 1,488 -1,287

BHC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BHC has a Quality Grade of C, ranking ahead of 53.93% of graded US stocks.
  • BHC's asset turnover comes in at 0.276 -- ranking 162nd of 680 Pharmaceutical Products stocks.
  • CCXI, NBY, and LLY are the stocks whose asset turnover ratios are most correlated with BHC.

The table below shows BHC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.714 -0.004
2021-03-31 0.259 0.714 0.006
2020-12-31 0.255 0.720 0.022
2020-09-30 0.250 0.721 -0.017
2020-06-30 0.252 0.725 -0.021
2020-03-31 0.265 0.729 -0.011

BHC Price Target

For more insight on analysts targets of BHC, see our BHC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $36.08 Average Broker Recommendation 1.62 (Moderate Buy)

BHC Stock Price Chart Interactive Chart >

Price chart for BHC

BHC Price/Volume Stats

Current price $7.87 52-week high $23.97
Prev. close $7.71 52-week low $4.00
Day low $7.72 Volume 488,796
Day high $7.89 Avg. volume 4,950,146
50-day MA $8.18 Dividend yield N/A
200-day MA $7.35 Market Cap 2.85B

Bausch Health Companies Inc. (BHC) Company Bio


Bausch Health Cos. Inc. (formerly) Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada.


BHC Latest News Stream


Event/Time News Detail
Loading, please wait...

BHC Latest Social Stream


Loading social stream, please wait...

View Full BHC Social Stream

Latest BHC News From Around the Web

Below are the latest news stories about BAUSCH HEALTH COMPANIES INC that investors may wish to consider to help them evaluate BHC as an investment opportunity.

12 Best Biotech Stocks To Buy Under $20

In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20. The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was […]

Yahoo | March 21, 2023

Implied Volatility Surging for Bausch Health (BHC) Stock Options

Investors need to pay close attention to Bausch Health (BHC) stock based on the movements in the options market lately.

Yahoo | March 21, 2023

Cortigent, developer of human vision restoration devices, files for $17M IPO

Seeking Alpha | March 20, 2023

Bausch Health Companies Inc. (NYSE:BHC) On The Verge Of Breaking Even

With the business potentially at an important milestone, we thought we'd take a closer look at Bausch Health Companies...

Yahoo | March 18, 2023

13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds

In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. According to a report by T.Rowe Price, healthcare stocks can be generally divided into two […]

Yahoo | March 4, 2023

Read More 'BHC' Stories Here

BHC Price Returns

1-mo -14.64%
3-mo 25.32%
6-mo 14.22%
1-year -65.56%
3-year -49.23%
5-year -50.57%
YTD 25.32%
2022 -77.25%
2021 32.74%
2020 -30.48%
2019 61.99%
2018 -11.12%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6519 seconds.